Zalevsky, Jonathan
Nektar Therapeutics (United States)
3 papers on CoChatORCID 0000-0003-2707-1709
Most cited papers
- Verified
JNK and Tumor Necrosis Factor-α Mediate Free Fatty Acid-induced Insulin Resistance in 3T3-L1 Adipocytes
Nguyen, M. T. A., Satoh, H., Favelyukis, S., Babendure, J. L., Imamura, T., Sbodio, J. I., Zalevsky, J., Dahiyat, B. I., Chi, N.-W., & Olefsky, J. M. (2005) · Journal of Biological Chemistry
Adipokines, Inflammation, and Metabolic DiseasesAdipose Tissue and Metabolism
Cited by 411
- Verified
Bempegaldesleukin (NKTR-214) plus Nivolumab in Patients with Advanced Solid Tumors: Phase I Dose-Escalation Study of Safety, Efficacy, and Immune Activation (PIVOT-02)
Diab, A., Tannir, N. M., Bentebibel, S.-E., Hwu, P., Papadimitrakopoulou, V., Haymaker, C., Kluger, H. M., Gettinger, S. N., Sznol, M., Tykodi, S. S., et al. (2020) · Cancer Discovery
Cancer Immunotherapy and BiomarkersImmunotherapy and Immune Responses
Cited by 237
- Verified
THU0054 NKTR-358, A NOVEL IL-2 CONJUGATE, STIMULATES HIGH LEVELS OF REGULATORY T CELLS IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS
Siddhanti, S., Fanton, C., Dixit, N., Lu, L., Chindalore, V., Levin, R., Diab, I., Furie, R., Zalevsky, J., & Kotzin, B. (2020) · Annals of the Rheumatic Diseases
Systemic Lupus Erythematosus ResearchT-cell and B-cell Immunology
Cited by 5
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free